Home
Finance
Companies
Industry
Market

Iterum Therapeutics Plc

Iterum Therapeutics Plc [ITRM] is -70.89% lower this YTD. Is it still time to buy?

November 19, 2025

Annabelle Farmer

Iterum Therapeutics Plc [NASDAQ: ITRM] gained 9.30% or 0.04 points to close at $0.4 with a heavy trading volume of ...

most recent

Companies

BofA Securities lifts United Micro Electronics ADR [UMC] price estimate. Who else is bullish?

Market

Iterum Therapeutics Plc [ITRM] is -70.89% lower this YTD. Is it still time to buy?

Industry

Market Analysts see Gilead Sciences, Inc [GILD] gaining to $140. Time to buy?

Finance

Viatris Inc [VTRS] Revenue clocked in at $14.06 billion, down -15.13% YTD: What’s Next?

Companies

CCC Intelligent Solutions Holdings Inc [CCC] moved up 2.42: Why It’s Important

Market

why Fiserv, Inc [FISV] is a Good Choice for Investors After New Price Target of $86.08

Who We Are

At DBT News, we cover what matters locally — with in-depth reporting, contributor perspectives, visual storytelling, and community feedback. Our goal is to keep you informed and engaged through open, respectful dialogue that rises above partisanship.

Quick Links

About Us
Contact Us
Disclaimer
Our Team
Privacy Policy

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Search for:

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled